bpc-157 unapproved new drug fda Did the Just Approve BPC-157? – Dr Brad Stanfield FDA Recommends Expanded BPC-157 Peptide

Safe disposal aligns with strict federal infection control standards

Hancock REW: Cationic peptides: effectors in innate immunity and novel antimicrobials

A formal Phase 2 trial was completed in 2009, but over 15 years later, the results have never been published, another major red flag suggesting it failed to prove effective or safe

(Some retailers circumvent these regulations and safety reviews, citing that the sale of these peptides is for research purposes or simply by using non-regulated, non-accredited pharmacies altogetherboth of which are red-flag practices that raise concerns about their overall safety practices.) Is GHK-Cu worth the hype